Watch the interview of Peter Guterstam and Nick Whitelock (Cytiva), and learn about
- the biological background of advanced therapeutics
- what mechanistic modelling is and why it fits into development of advanced therapeutics.
- what the challenges are in process development when working with both diverse molecules and mechanistic modeling.